| Literature DB >> 26661211 |
Pasquale Molinaro1, Rossana Sirabella2, Giuseppe Pignataro1, Tiziana Petrozziello1, Agnese Secondo1, Francesca Boscia1, Antonio Vinciguerra1, Ornella Cuomo1, Kenneth D Philipson3, Mario De Felice4, Roberto Di Lauro4, Gianfranco Di Renzo1, Lucio Annunziato5.
Abstract
Three different Na+/Ca2+ exchanger (NCX) isoforms, NCX1, NCX2, and NCX3, are expressed in brain where they play a relevant role in maintaining Na+ and Ca2+ homeostasis. Although the neuroprotective roles of NCX2 and NCX3 in stroke have been elucidated, the relevance of NCX1 is still unknown because of embryonic lethality of its knocking-out, heart dysfunctions when it is overexpressed, and the lack of selectivity in currently available drugs. To overcome these limitations we generated two conditional genetically modified mice that upon tamoxifen administration showed a selective decrease or increase of NCX1 in cortical and hippocampal neurons. Interestingly, in cortex and hippocampus NCX1 overexpression increased, where NCX1 knock-out reduced, both exchanger activity and Akt1 phosphorylation, a neuronal survival signaling. More important, mice overexpressing NCX1 showed a reduced ischemic volume and an amelioration of focal and general deficits when subjected to transient middle cerebral artery occlusion. Conversely, NCX1-knock-out mice displayed a worsening of brain damage, focal and neurological deficits with a decrease in Akt phosphorylation. These results support the idea that NCX1 overexpression/activation may represent a feasible therapeutic opportunity in stroke intervention.Entities:
Keywords: Akt; Cre-LoxP; NCX1; Na+-Ca2+ exchanger; stroke
Mesh:
Substances:
Year: 2015 PMID: 26661211 PMCID: PMC5076784 DOI: 10.1177/0271678X15611913
Source DB: PubMed Journal: J Cereb Blood Flow Metab ISSN: 0271-678X Impact factor: 6.200